Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gorlick

Showing results (1-10 of 281) with videos related to

Pageof 29
Sort By:
Cancer Treatment and Research|March 10, 2010
Current concepts on the molecular biology of osteosarcomaRichard Gorlick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptanceNorman Jaffe, Richard Gorlick
Expert Review of Anticancer Therapy|March 22, 2003
Fluoropyrimidine resistance in colon cancerRichard Gorlick, Debabrata Banerjee
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 6, 2010
OsteosarcomaRichard Gorlick, Chand Khanna
Nature Reviews. Clinical Oncology|June 16, 2021
Advancing therapy for osteosarcomaJonathan Gill, Richard Gorlick
Cancer Biology & Therapy|April 28, 2009
Immune approaches to treating osteosarcomaNeyssa Marina, Richard Gorlick
Expert Review of Anticancer Therapy|April 21, 2009
Novel therapeutic agents for osteosarcomaKathleen O'Day, Richard Gorlick
Expert Review of Anticancer Therapy|July 13, 2006
Chemotherapy resistance in osteosarcoma: current challenges and future directionsAlexander J Chou, Richard Gorlick
The Lancet. Oncology|August 12, 2016
The case for informative phase 2 trials in osteosarcomaKatherine A Janeway, Richard Gorlick
Journal of Pediatric Hematology/Oncology|November 11, 2003
Osteosarcoma necrosis following chemotherapy: innate biology versus treatment-specificRichard Gorlick, Paul A Meyers
Pageof 29

Showing results (1-10 of 281) with videos related to

Sort By:
Pageof 29
Cancer Treatment and Research|March 10, 2010
Current concepts on the molecular biology of osteosarcomaRichard Gorlick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptanceNorman Jaffe, Richard Gorlick
Expert Review of Anticancer Therapy|March 22, 2003
Fluoropyrimidine resistance in colon cancerRichard Gorlick, Debabrata Banerjee
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 6, 2010
OsteosarcomaRichard Gorlick, Chand Khanna
Nature Reviews. Clinical Oncology|June 16, 2021
Advancing therapy for osteosarcomaJonathan Gill, Richard Gorlick
Cancer Biology & Therapy|April 28, 2009
Immune approaches to treating osteosarcomaNeyssa Marina, Richard Gorlick
Expert Review of Anticancer Therapy|April 21, 2009
Novel therapeutic agents for osteosarcomaKathleen O'Day, Richard Gorlick
Expert Review of Anticancer Therapy|July 13, 2006
Chemotherapy resistance in osteosarcoma: current challenges and future directionsAlexander J Chou, Richard Gorlick
The Lancet. Oncology|August 12, 2016
The case for informative phase 2 trials in osteosarcomaKatherine A Janeway, Richard Gorlick
Journal of Pediatric Hematology/Oncology|November 11, 2003
Osteosarcoma necrosis following chemotherapy: innate biology versus treatment-specificRichard Gorlick, Paul A Meyers
Pageof 29